Abstract 5010: Targeting of AKT pathway inhibit high-risk neuroblastoma growth

High-risk neuroblastoma (NB) represents a major clinical challenge in pediatric oncology. Despite intensive genotoxic therapies, long-term survival for NB patients remains poor ( Citation Format: Rameswari Chilamakuri, Saurabh Agarwal. Targeting of AKT pathway inhibit high-risk neuroblastoma growth [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 5010.